Poorly differentiated neuroendocrine tumor of the larynx: challenging and highly aggressive.
Arroyo
Sherley Valdez
SV
Department of Neurology, Tulane University Medical Center, New Orleans, USA.
Rosel
Paul
P
Palacios
Enrique
E
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018278:Carcinoma, Neuroendocrine / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000556:secondary / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006261:Headache; D006685:Hoarseness; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy; D007828:Laryngoscopy; D053609:Lethargy; D008279:Magnetic Resonance Imaging; D018714:Radiotherapy, Adjuvant; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D005047:Etoposide; D002945:Cisplatin